Views & Analysis | Perspectives on pharma industry issues

R&D

Changing Faces: Board of Directors and Advisory Boards, Marc...

Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.

Market Access

Health, growth & renewal: ABPI 2026 looks to UK’s future

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

Digital

4 Takeaways from Google Cloud’s NEXT 2026 and what’s on the ...

When you attend events hosted by industry leaders like Google, you expect to be impressed by how technology continues to evolve.

R&D

How automation can drive a competitive advantage for CROs & ...

For CROs and CDMOs, automation is key to ensuring long-term success.

R&D

Gloved lab hand holds petri dish with AMR test

AI can help us build a new, more precise, antibiotic pipelin...

AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.

Oncology

CAR-TCR 2023 – Josh Ludwig

Innovation was the watchword at CAR-TCR in Boston last month, but one of the limitations of innovation is that it can be challenging for an industry to transition from the rapid iteration s

Digital

How AI and omnichannel are transforming pharma marketing

Artificial intelligence is transforming nearly every industry these days, and in biopharma that goes for every part of the business -- from research and development to marketing and communi

Patients

Benefits of including QR codes on medication packaging

Used correctly, prescription medication helps heal illnesses, manage chronic conditions, and more.

Sales & Marketing

pharmaphorum podcast Episode 257, John Holodnak, Occam

A philosophical look at market turn in the Age of AI, with J...

John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.

Sales & Marketing

Changing Faces: Agency, consultancy, and investor, March 202...

March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.

Digital

4 Takeaways from Google Cloud’s NEXT 2026 and what’s on the ...

When you attend events hosted by industry leaders like Google, you expect to be impressed by how technology continues to evolve.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Market Access

Health, growth & renewal: ABPI 2026 looks to UK’s future

The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.

Market Access

The companies shaping the UK’s commercial landscape

Which companies are working with the government to implement the US-UK pharmaceutical trade agreement?

Oncology

From promise to practice: What must happen next for genetic ...

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

Oncology

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Oncology

From preclinical toxicology to clinical safety: The path for...

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

Patients

Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

Sales & Marketing

Digital

Market Access

Editor's Picks

Oncology

Patients

R&D

Editor's Picks